Johnson & Johnson (JNJ) Dividend Coverage Ratio Growth (1y) (2010 - 2026)
Powered by 
Analysis
Johnson & Johnson (JNJ) Dividend Coverage Ratio Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.10 Bn | 625.34 Bn | 17.26 Bn | -3.09% |
| 2 | AbbVie | 441.68 Bn | 435.11 Bn | 12.70 Bn | 264.24% |
| 3 | Merck | 366.62 Bn | 359.48 Bn | 12.21 Bn | -129.25% |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn | -30.09% |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | -108.11% |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | -92.21% |
| 7 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | - |
| 8 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.54 Bn | 18.88 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -3.09% |
| Mar 29, 2026 | -54.56% |
| Dec 28, 2025 | 42.11% |
| Sep 28, 2025 | 82.26% |
| Jun 29, 2025 | 12.72% |
| Mar 30, 2025 | 224.34% |
| Dec 29, 2024 | -18.64% |
| Sep 29, 2024 | -90.04% |
| Jun 30, 2024 | -5.64% |
| Mar 31, 2024 | 5,008.56% |
| Dec 31, 2023 | 65.30% |
| Apr 2, 2023 | -101.27% |
| Apr 3, 2022 | -21.97% |
| Oct 3, 2021 | -1.70% |
| Jul 4, 2021 | 64.95% |
| Apr 4, 2021 | 0.73% |
| Jan 3, 2021 | -59.23% |
| Sep 27, 2020 | 90.54% |
| Jun 28, 2020 | -38.66% |
| Mar 29, 2020 | 47.87% |